Received: 4 June 2020
Accepted: 2 February 2021
First Online: 9 February 2021
Ethics approval and consent to participate
: The study was approved by the Clinical Research Ethics Committee of the “Hospital General Universitario Gregorio Marañón” (reference number 127/13) and the “Área de Control Farmacéutico y Productos Sanitarios, Consejería de Sanidad, Comunidad de Madrid” (reference number 07/071012.9/15), and was carried out in accordance with the ethical Declaration of Helsinki in 1964. Written informed consent was obtained from all patients.
: Not applicable.
: LM, VF and JO served as speakers and/or consultants for General Electric Healthcare. HM-L, FB, JG-L and JCA-F: non-declared.